David S. Ettinger
Johns Hopkins University · 479 works · 28,185 citations · h-index 82
Top works
- Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.
- Phase I trial of taxol in patients with advanced cancer.
- American Cancer Society lung cancer screening guidelines
- Multidisciplinary Management of Lung Cancer
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
- Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP-16 in small-cell carcinoma of the lung
- Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.
- Non–Small Cell Lung Cancer
- Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
- Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
- Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung
- NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
- Variable Content of Histaminase, L-Dopa Decarboxylase and Calcitonin in Small-Cell Carcinoma of the Lung
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
- Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
- Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.